Concepts and challenges of biosimilars to mitigate the oncology drug expenses

Concepts and challenges of biosimilars to mitigate the oncology drug expenses

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.

Bibliografiset tiedot
Päätekijä:	Tania, Umme
Muut tekijät:	Haque , Md. Aminul
Aineistotyyppi:	Opinnäyte
Kieli:	en_US
Julkaistu:	Brac University 2021
Aiheet:	Biosimilars Interchangeability Cancer therapy Monoclonal antibodies Biologic medicines Comparability exercise
Linkit:	http://hdl.handle.net/10361/15111

Samankaltaisia teoksia

Biosimilar in lymphoma treatment
Tekijä: Tanisha, Mehrin Haque
Julkaistu: (2021)

Biosimilar insulins: a potential option in the treatment of Diabetes
Tekijä: Tabassum, Turana
Julkaistu: (2022)

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
Tekijä: Tania, Umme
Julkaistu: (2023)

Advancement of Antibody-Drug conjugates in cancer treatment: A review
Tekijä: Sagar, Baejid Hossain
Julkaistu: (2022)

Immunotherapeutic approaches to treat cancer: Prospects and challenges
Tekijä: Fred, Namanda Rogers
Julkaistu: (2021)

A review on targeted therapies for lung cancer
Tekijä: Ashraf, Anushey
Julkaistu: (2023)

Osteoarthritis: a multi-disciplinary factual review
Tekijä: Subah, Nowshin
Julkaistu: (2021)

Biosimilars: A revolution for biologics in the pharmaceutical industry
Tekijä: Moreino, Shannon Sherwin
Julkaistu: (2018)

Biologics and Biosimilars as Treatment Options for Psoriasis
Tekijä: Moya, Amena Khatun
Julkaistu: (2023)

Targeted therapeutic options in the treatment of Breast Cancer
Tekijä: Alam, Kazi Tasnuva
Julkaistu: (2022)

In vivo propagation of monoclonal antibodies in ascites fluid produced in BALB/c mice: characterization and diagnostic application for the identification of Vibrio cholerae O1
Tekijä: Chowdhury, Mashiat Nawar
Julkaistu: (2018)

A review on bispecific antibody (blinatumomab) for the treatment of acute lymphoblastic leukemia
Tekijä: Choki, Kinley
Julkaistu: (2024)

Post Covid-19 health indications of Covid-19 patients
Tekijä: Khan, Tanzim
Julkaistu: (2022)

Recent advancement of biologics in Asthma
Tekijä: Evan, Al- Shahriar
Julkaistu: (2022)

PCSK9i: proprotein convertase subtilisin/kexin type 9 inhibitor a new phase of lipid-lowering treatment
Tekijä: Lubaba, Anikah
Julkaistu: (2024)

A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
Tekijä: Ratu, Tabassum
Julkaistu: (2024)

A comprehensive review on drug repurposing in cancer treatment
Tekijä: Sarkar, Onusree
Julkaistu: (2024)

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
Tekijä: Chakraborty, Anuradha
Julkaistu: (2024)

A review on the recent advancements on nanoparticles drug delivery approaches in anti-cancer treatment
Tekijä: Hoque, Syeda Mehren
Julkaistu: (2024)

Breast cancer therapy through Liposomal drug delivery system
Tekijä: Ome, Nusrat Jahan
Julkaistu: (2024)

An improved chromosome sorting algorithm by permutation group-based inverted block-interchanges
Tekijä: Tabassum, Afrida, et al.
Julkaistu: (2018)

Pharmacokinetics, safety, efficacy and immunogenicity of Adalimumab biosimilar ABP-501in rheumatoid arthritis and plaque psoriasis
Tekijä: Akter, Anika
Julkaistu: (2022)

Risk of cancer associated with antihypertensive drugs
Tekijä: Iqbal, Adnan
Julkaistu: (2024)

RIPK pathway, as a potential target, for cancer treatment - a review
Tekijä: Jahan, Nusrat
Julkaistu: (2024)

Study on anticancer drugs approved by the FDA from 2014 to 2023
Tekijä: Rattry, Faria Rahman
Julkaistu: (2024)

Clinical outcomes and safety comparison of gemcitabine plus cisplatin, capecitabine monotherapy, and gemcitabine plus oxaliplatin in the management of gallbladder carcinoma: a comprehensive meta-analysis
Tekijä: Rahman, Sanjida
Julkaistu: (2024)

Genetic innovations for breast cancer treatment : a review of gene therapy strategies and future implications
Tekijä: Hasan, Sakib
Julkaistu: (2024)

Immunotherapy in the Management of Lung Cancer
Tekijä: Tasnim, Humayra
Julkaistu: (2022)

Biosimilars
Julkaistu: (2013)

Biosimilars

Art therapy to improve quality of life of cancer patients and their carers in Bangladesh
Tekijä: Dowla, Rumana, et al.
Julkaistu: (2022)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
Tekijä: Razna, Amrin Islam
Julkaistu: (2019)

Therapeutic prospective of targeting calcium homeostasis in cancer – a review
Tekijä: Kamal, Tasnova
Julkaistu: (2019)

A review on carbon nanotube: a new era in cancer diagnosis & therapy
Tekijä: Parvez, Safi
Julkaistu: (2023)

Sugar based biopolymers in nanomedicine: a review
Tekijä: Juthy, Afrin Rahman
Julkaistu: (2024)

A review on combinatorial therapies in Melanoma
Tekijä: Ahmmed, Md. Kawsar
Julkaistu: (2024)

An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer
Tekijä: Hasan, Amit
Julkaistu: (2024)

A review on nanoparticles based drug delivery in cancer treatment: advantages & challenges
Tekijä: Nahar, Kamrun
Julkaistu: (2023)

The impact of cell penetrating peptides in prospective cancer therapy: a review
Tekijä: Nashrah, Zannatul
Julkaistu: (2023)

Food, nutrition, physical activity and the prevention of cancer : a global perspective : a project of World Cancer Research Fund International.
Julkaistu: (2007)